Jan Groen has joined the board of ANGLE Plc as a non-executive director with a remit to assist the UK company commercialise its liquid biopsy tests for cancer. Dr Groen is chief executive of MDxHealth, a Euronext listed molecular diagnostic company. Prior to this, he was global chief operating office at Agendia Inc. He has been involved in the development of more than 25 diagnostic products which have been approved by regulatory authorities in both the EU and the US.
ANGLE announced the appointment on 1 November 2018.
Copyright 2018 Evernow Publishing Ltd